cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
05 2019
Historique:
received: 27 09 2018
accepted: 11 04 2019
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 22 7 2020
Statut: epublish

Résumé

The ability of cytosolic lipopolysaccharide (LPS) to activate caspase-11-dependent nonclassical inflammasome is intricately controlled to avoid excessive inflammatory responses. However, very little is known about the regulatory role of various metabolic pathways in the control of caspase-11 activation. Here, we demonstrate that l-adrenaline can act on receptor ADRA2B to inhibit the activation of the caspase-11 inflammasome by cytosolic LPS or

Identifiants

pubmed: 31131320
doi: 10.1126/sciadv.aav5562
pii: aav5562
pmc: PMC6531004
doi:

Substances chimiques

ADRA2B protein, human 0
Adra2b protein, mouse 0
Inflammasomes 0
Lipopolysaccharides 0
Receptors, Adrenergic, alpha-2 0
Cyclic AMP E0399OZS9N
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Casp4 protein, mouse EC 3.4.22.-
Caspases EC 3.4.22.-
Caspases, Initiator EC 3.4.22.-
caspase 11, human EC 3.4.22.-
Adenylyl Cyclases EC 4.6.1.1
adenylyl cyclase 4 EC 4.6.1.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaav5562

Subventions

Organisme : NCI NIH HHS
ID : R01 CA211070
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT005076
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM044100
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM127027
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM063075
Pays : United States

Références

Nat Rev Immunol. 2003 Feb;3(2):169-76
pubmed: 12563300
J Clin Invest. 2017 Nov 1;127(11):4124-4135
pubmed: 28990935
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7628-33
pubmed: 12032334
Nat Commun. 2014 Jul 14;5:4436
pubmed: 25019241
J Immunol. 2005 Jan 15;174(2):595-9
pubmed: 15634874
Cell Metab. 2014 Jun 3;19(6):1058-65
pubmed: 24768298
Transl Med UniSa. 2016 Nov 01;15:67-73
pubmed: 27896229
Science. 2013 Sep 13;341(6151):1250-3
pubmed: 24031018
Nature. 2012 Dec 6;492(7427):123-7
pubmed: 23143333
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
Nature. 2014 Oct 9;514(7521):187-92
pubmed: 25119034
Science. 2013 Feb 22;339(6122):975-8
pubmed: 23348507
Mediators Inflamm. 2017;2017:2860956
pubmed: 28348460
Science. 2013 Sep 13;341(6151):1246-9
pubmed: 23887873
J Gen Physiol. 2014 Jan;143(1):9-15
pubmed: 24378903
Nat Immunol. 2016 Oct;17(10):1176-86
pubmed: 27548431
JAMA. 2013 Mar 20;309(11):1154-62
pubmed: 23512062
Cell Host Microbe. 2018 Jul 11;24(1):97-108.e4
pubmed: 29937272
J Biol Chem. 1956 Jan;218(1):459-68
pubmed: 13278353
Mol Med Rep. 2016 May;13(5):3715-23
pubmed: 27035868
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Nat Rev Drug Discov. 2009 Apr;8(4):321-35
pubmed: 19337273
Cell Metab. 2009 Mar;9(3):265-76
pubmed: 19254571
Nat Commun. 2016 Oct 25;7:13280
pubmed: 27779186
P T. 2015 Jul;40(7):438-50
pubmed: 26185405
Cell Rep. 2018 Jul 10;24(2):366-378
pubmed: 29996098
Cell. 1998 Feb 20;92(4):501-9
pubmed: 9491891
Cell. 2015 Jan 15;160(1-2):62-73
pubmed: 25594175
Immunity. 2016 Oct 18;45(4):802-816
pubmed: 27692610
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
J Exp Med. 2016 Oct 17;213(11):2365-2382
pubmed: 27697835
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
J Immunol. 2005 Aug 1;175(3):1523-31
pubmed: 16034090
J Cell Biol. 2010 Sep 6;190(5):881-92
pubmed: 20819940
J Immunol. 2015 Jun 1;194(11):5472-5487
pubmed: 25917098
Nature. 2011 Oct 16;479(7371):117-21
pubmed: 22002608
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Biochim Biophys Acta. 2004 Mar 11;1697(1-2):259-69
pubmed: 15023366
Nature. 2016 Jul 7;535(7610):111-6
pubmed: 27281216
Front Immunol. 2016 Mar 31;7:123
pubmed: 27065076

Auteurs

Ruochan Chen (R)

The Third Affiliated Hospital, Protein Modification and Degradation Laboratory, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510510, China.
Department of Infectious Diseases and State Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Ling Zeng (L)

State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Research Institute for Traffic Medicine of People's Liberation Army, Daping Hospital, Third Military Medical University, Chongqing 400042, China.

Shan Zhu (S)

The Third Affiliated Hospital, Protein Modification and Degradation Laboratory, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510510, China.
Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Jiao Liu (J)

The Third Affiliated Hospital, Protein Modification and Degradation Laboratory, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510510, China.

Herbert J Zeh (HJ)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Guido Kroemer (G)

Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France.
Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France.
Université Pierre et Marie Curie, 75006 Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France.
Department of Women's and Children's Health, Karolinska University Hospital, 17176 Stockholm, Sweden.

Haichao Wang (H)

Laboratory of Emergency Medicine, North Shore University Hospital and The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA.

Timothy R Billiar (TR)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.

Jianxin Jiang (J)

State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Research Institute for Traffic Medicine of People's Liberation Army, Daping Hospital, Third Military Medical University, Chongqing 400042, China.

Daolin Tang (D)

The Third Affiliated Hospital, Protein Modification and Degradation Laboratory, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510510, China.
Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Rui Kang (R)

Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH